BZ7A.F Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 Apr 2024 @ 08:24):

Stats
Tagesvolumen	500.00
Durchschnittsvolumen	8.00
Marktkapitalisierung	4.85B
EPS	€2.01 ( 2023-06-30 )
Last Dividend	€1.350 ( 2023-08-24 )
Next Dividend	€0 ( N/A )
P/E	29.05
ATR14	€0.0310 (0.51%)

Volumen Korrelation

Lang: -0.04 (neutral)

Kurz: 0.04 (neutral)

Signal:(61.295) Neutral

Bumrungrad Hospital Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Bumrungrad Hospital Korrelation - Währung/Rohstoff

0.04
( neutral )

-0.27
( neutral )

-0.23
( neutral )

-0.20
( neutral )

-0.84
( strong negative )

-0.24
( neutral )

Bumrungrad Hospital Finanzdaten

Annual	2023
Umsatz:	€25.38B
Bruttogewinn:	€12.48B (49.19 %)
EPS:	€8.81

FY	2023
Umsatz:	€25.38B
Bruttogewinn:	€12.48B (49.19 %)
EPS:	€8.81

FY	2022
Umsatz:	€20.72B
Bruttogewinn:	€9.62B (46.43 %)
EPS:	€6.21

Financial Reports:

No articles found.

Bumrungrad Hospital Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
€1.150 (N/A)	€0 (N/A)	€2.35 (N/A)	€0 (N/A)	€1.350 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)

Bumrungrad Hospital Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.74 - Stable (14.87%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	€0.400	2008-04-29
Last Dividend	€1.350	2023-08-24
Next Dividend	€0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	33	--
Total Paid Out	€36.65	--
Avg. Dividend % Per Year	0.00%	--
Score	4.08	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.74
Div. Directional Score	9.18	--

Next Divdend (Est)
(2024-06-21)

€1.337 Estimate 7.54 %

Dividend Stability

0.30 Poor

Dividend Score

4.08

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for XETRA

Symbol	Title	Last dividend	Frequency	Yearly Dividend
MUB.DE	Ex Dividend Junior	2023-08-11	Annually	0.00%
7BP.F	Ex Dividend Knight	2023-09-06	Annually	0.00%
WIB.DE	Ex Dividend Knight	2023-05-09	Annually	0.00%
FME.DE	Ex Dividend Junior	2023-05-17	Annually	0.00%
PBB.DE	Ex Dividend Junior	2023-05-26	Annually	0.00%
APC.F	Ex Dividend Knight	2023-08-11	Quarterly	0.00%
HHFA.DE	Ex Dividend Junior	2023-06-16	Annually	0.00%
SAP.DE	Ex Dividend Knight	2023-05-12	Annually	0.00%
CBHD.DE	Ex Dividend Knight	2023-05-15	Semi-Annually	0.00%
KHNZ.DE	Ex Dividend Knight	2023-08-31	Quarterly	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.287	1.500	4.27	6.40	[0 - 0.5]
returnOnAssetsTTM	0.237	1.200	2.08	2.50	[0 - 0.3]
returnOnEquityTTM	0.319	1.500	7.56	10.00	[0.1 - 1]
payoutRatioTTM	0.397	-1.000	6.03	-6.03	[0 - 1]
currentRatioTTM	4.29	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	4.16	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	0.639	1.500	7.56	10.00	[0.2 - 2]
debtRatioTTM	0.00473	-1.500	9.92	-10.00	[0 - 0.6]
interestCoverageTTM	2 236.39	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	9.62	2.00	6.79	10.00	[0 - 30]
freeCashFlowPerShareTTM	7.40	2.00	6.30	10.00	[0 - 20]
debtEquityRatioTTM	0.00572	-1.500	9.98	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.501	1.000	4.98	4.98	[0.2 - 0.8]
operatingProfitMarginTTM	0.348	1.000	5.05	5.05	[0.1 - 0.6]
cashFlowToDebtRatioTTM	51.77	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.828	0.800	7.81	6.25	[0.5 - 2]
Total Score				12.62

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	25.71	1.000	7.50	0	[1 - 100]
returnOnEquityTTM	0.319	2.50	8.43	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	7.40	2.00	7.53	10.00	[0 - 30]
dividendYielPercentageTTM	1.878	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	9.62	2.00	6.79	10.00	[0 - 30]
payoutRatioTTM	0.397	1.500	6.03	-6.03	[0 - 1]
pegRatioTTM	0.0775	1.500	-2.82	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.296	1.000	5.11	0	[0.1 - 0.5]
Total Score				5.74

Bumrungrad Hospital

Bumrungrad Hospital Public Company Limited owns and operates healthcare-related entities in Thailand and internationally. The company offers diagnostic, therapeutic, and intensive care facilities in a medical center. Its outpatient clinics/centers include allergy, arrhythmia, behavioral health, breastfeeding, breast care, children, dental, diabetes, diagnostic, dialysis, digestive disease, emergency, eye, fertility and IVF, health screening, hearing and balance, heart valve, cancer, hyperbaric oxygen therapy, hypertension, joint replacement, liver, memory, men, nephrology, neuroscience, new life healthy aging, orthopedic, Parkinson's disease and movement disorders, perinatal, physical therapy and rehabilitation, plastic surgery, pulmonary, refractive surgery, robotic scoliosis and surgery, skin, sleep lab, spine, sports medicine and lifestyle, surgical, travel medicine, urology, vitalife, and women's, as well as ear, nose, and throat centers. In addition, the company is involved in the real estate assets holding activities; provision of clinical research services; distribution of pharmaceutical and medical goods in specialized stores; operation of personnel development and training center for healthcare services; and patient referral service business. It operates 580 beds and approximately 56 clinics/centers. The company was founded in 1980 and is headquartered in Bangkok, Thailand.